NCT07747155 — "A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis" trial site landscape

Public-registry site landscape for NCT07747155, “A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis”, a Ulcerative Colitis (UC) study sponsored by Pyrotech Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07747155 (registry record)
Study title	A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis
Official title	A Phase IIa, Multicenter, Single-Arm Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Characteristics of PTT-621 in Patients With Moderately to Severely Active Ulcerative
Sponsor	Pyrotech Therapeutics, Inc.
Condition(s)	Ulcerative Colitis (UC)
Phase	PHASE2
Listed sites	1
Site countries	China

Patient-friendly overview of this study: eichor.com/study/NCT07747155.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07747155 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →